How to Buy Rapport Therapeutics Stock

Rapport Therapeutics Inc

Rapport Therapeutics is a biotech company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker RAPP on the NASDAQ exchange.

Rapport Therapeutics stock last closed at $10.38, up 2.27% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Rapport Therapeutics stock is currently +61.43% from its 52-week low of $6.43, and -65.1% from its 52-week high of $29.74.

There are currently 36.5M RAPP shares outstanding. The market capitalization of RAPP is $378.83M. In the last 24 hours, 118,746 RAPP shares were traded.

How to Buy Rapport Therapeutics Stock

Wondering how to invest in Rapport Therapeutics stock? Here's how.

  1. Choose where to buy Rapport Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Rapport Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Select your method of payment and add your details.
  4. Evaluate Rapport Therapeutics stock: The Rapport Therapeutics ticker symbol is RAPP. Is Rapport Therapeutics stock a good investment? Should you buy shares of RAPP? How do RAPP's underlying business fundamentals look? Do top analysts think Rapport Therapeutics is a good buy? Why has RAPP's stock price moved recently? (Hint: Our stock research website can help you evaluate if RAPP is a good stock to buy).
  5. Make your RAPP buy order: Decide if you will purchase RAPP shares at the current market price or use a limit order to purchase RAPP stock at a specific price.
  6. Keep an eye on your RAPP investment: Create a watchlist to track your investment in Rapport Therapeutics stock.

Step 1: Choose where to buy Rapport Therapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy RAPP stock.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the right brokerage, the next step is to fill out some personal details so you can invest in RAPP today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal details to create a new brokerage account.
  1. Submit your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you've finished signing up on stock market apps, you can securely and quickly fund your account:

Check out the video below for more details depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Rapport Therapeutics stock

After you have identified the best place to buy Rapport Therapeutics stock, it's important to research their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.

Rapport Therapeutics stock quick numbers

RAPP Price
$10.38
1w %
5.49%
1y %
N/A
5y %
N/A
P/E
-2.75x
P/B
1.24x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$78.31M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$378.83M
Next Earnings
N/A
Next Dividend
N/A

RAPP Due Diligence Score

WallStreetZen was created to help average investors perform more accurate fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on RAPP's stock page.

What is the fair value of RAPP stock?

Investors use many financial metrics, analyses, models, and charts to gauge RAPP's intrinsic value.

Using relative valuations ratios:

  • RAPP may be undervalued based on its P/B ratio of 1.24x, relative to Biotechnology industry P/B ratio of 4.04x

You can do additional valuation analysis on RAPP's stock here.

Is RAPP a healthy company?

Positive Health Checks:

  • RAPP has $305.39M in cash and short term investments. This is enough to cover its annual cash burn of $67.23M.
  • RAPP has cash burn of 67233000. It has sufficient cash and short-term investments to cover this for at least one year.
  • RAPP has a low debt to equity ratio of 0.03.
  • There are more short-term assets than short-term liabilities on the RAPP balance sheet.
  • There are more short-term assets than long-term liabilities on the RAPP balance sheet.

Is RAPP stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 1 Wall Street analysts who give forecasts on RAPP, the consensus analyst rating on RAPP is a Buy

It's important to note that analyst ratings are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Rapport Therapeutics stock forecast page.

RAPP Technical Indicators

SMA10
9.48
SMA20
9.58
SMA50
10.79
SMA100
14.33
SMA200
18.27
MACD
-0.21
MACD Signal
-0.45
MACD Histogram
0.23
RSI
53.66
Stochastic %K
71.41
Stochastic %D
64.85
StochRSI %K
98.86
StochRSI %D
95.96

Latest Insiders Trades at RAPP

In the last 12 months, executives and large shareholders at RAPP have bought more shares than they have sold.

David Bredt, Chief Scientific Officer of RAPP, was the latest RAPP insider to sell. They sold $81,311.00 worth of RAPP stock on Apr 15, 2025.

Learn more about who owns RAPP shares here.

Can I get consistent income from RAPP stock?

No, Rapport Therapeutics doesn't provide an income stream by paying out dividends.

Get analysis from other traders

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Make your RAPP buy order

There are two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a specific dollar amount, use a limit order.

Click the Open Trade button and your broker will execute your order.

If you want additional info about investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep an eye on your RAPP investment

Now that you own some RAPP stock, you'll want to stay up-to-date on your investment.

Make a watchlist to track the latest developments regarding your RAPP stock.

RAPP Feed

How to Buy Stock in Rapport Therapeutics

To summarize, here are the 6 steps to buy Rapport Therapeutics stock:

  1. Choose where to buy Rapport Therapeutics stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Evaluate Rapport Therapeutics stock
  5. Make your RAPP buy order
  6. Keep an eye on your RAPP investment

If you need a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your investment in Rapport Therapeutics, click below.

NASDAQ: RAPP
$10.38+0.23 (+2.27%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: RAPP
$10.38+0.23 (+2.27%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Rapport Therapeutics share?

As of Apr 21, 2025, it costs $10.38 to buy one share of Rapport Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.482 shares of RAPP.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Rapport Therapeutics stock?

According to 1 Wall Street analysts who monitor Rapport Therapeutics, their consensus recommendation is to buy Rapport Therapeutics stock.

What is the best way to buy Rapport Therapeutics stock?

One way to place an order for Rapport Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.